Robert Simmons
Stock Analyst at Rosenblatt
(1.37)
# 3,498
Out of 5,182 analysts
40
Total ratings
43.48%
Success rate
-0.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Simmons
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WDAY Workday | Maintains: Buy | $180 → $150 | $117.86 | +27.27% | 10 | Feb 25, 2026 | |
| BL BlackLine | Maintains: Buy | $62 | $31.03 | +99.81% | 3 | Feb 11, 2026 | |
| PHR Phreesia | Maintains: Buy | $36 → $34 | $8.60 | +295.35% | 6 | Apr 14, 2025 | |
| ASAN Asana | Maintains: Neutral | $20 | $5.49 | +264.30% | 6 | Mar 12, 2024 | |
| MNDY monday.com | Upgrades: Buy | $170 | $61.69 | +175.57% | 6 | Nov 7, 2023 | |
| GDRX GoodRx Holdings | Upgrades: Buy | $9.5 | $2.23 | +326.01% | 2 | Aug 10, 2023 | |
| PCTY Paylocity Holding | Upgrades: Buy | $245 | $97.92 | +150.20% | 2 | Mar 30, 2023 | |
| PAYC Paycom Software | Upgrades: Buy | $350 | $119.84 | +192.06% | 3 | Mar 30, 2023 | |
| TDOC Teladoc Health | Maintains: Buy | $45 → $40 | $5.24 | +663.36% | 2 | Oct 25, 2022 |
Workday
Feb 25, 2026
Maintains: Buy
Price Target: $180 → $150
Current: $117.86
Upside: +27.27%
BlackLine
Feb 11, 2026
Maintains: Buy
Price Target: $62
Current: $31.03
Upside: +99.81%
Phreesia
Apr 14, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $8.60
Upside: +295.35%
Asana
Mar 12, 2024
Maintains: Neutral
Price Target: $20
Current: $5.49
Upside: +264.30%
monday.com
Nov 7, 2023
Upgrades: Buy
Price Target: $170
Current: $61.69
Upside: +175.57%
GoodRx Holdings
Aug 10, 2023
Upgrades: Buy
Price Target: $9.5
Current: $2.23
Upside: +326.01%
Paylocity Holding
Mar 30, 2023
Upgrades: Buy
Price Target: $245
Current: $97.92
Upside: +150.20%
Paycom Software
Mar 30, 2023
Upgrades: Buy
Price Target: $350
Current: $119.84
Upside: +192.06%
Teladoc Health
Oct 25, 2022
Maintains: Buy
Price Target: $45 → $40
Current: $5.24
Upside: +663.36%